Back to Trades
Booth Andrew
Chief Financial OfficerCIK 0001834411
Profile
- Filings
- 3
- Buy transactions
- 1
- Sell transactions
- 0
- Companies
- 1
- Active
- 2026
Across 3 filings between 2026, Booth Andrew, Chief Financial Officer, has disclosed $3.2M in transactions — all concentrated in AbCellera Biologics Inc. (ABCL). Their disclosed trades are heavily weighted toward buying — $383.9K in buys and $0 in sells. The largest single open-market purchase on record is $383.9K in AbCellera Biologics Inc.. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
3 loaded
| Aug 14 | ABCL AbCellera Biologics Inc. | Booth Andrew | Chief Financial Officer | Buy | $383.9K |
| Jun 3 | ABCL AbCellera Biologics Inc. | Booth Andrew | Chief Financial Officer | Exercise | $95.0K |
| Jan 5 | ABCL AbCellera Biologics Inc. | Booth Andrew | Chief Financial Officer | Award | $2.8M |
3 filings